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INTRODUCTION
Neovascularization is the growth of new capillary blood vessels 
in the body, and is an important natural process for healing 
and reproduction. The body controls neovascularization 
by producing a precise balance of growth and inhibitory 
factors in healthy tissues. When this balance is disturbed, the 
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ABSTRACT
Angiogenesis represents an excellent therapeutic target for the treatment of cardiovascular diseases. It is a 
potent physiological process that underlies the natural manner in which our bodies respond to a diminution 
of blood supply to vital organs, namely the production of new collateral vessels to overcome the ischemic 
state. This present study is aimed to evaluate and quantify the Angiogenic potential of Terminalia bellirica 
Roxb, by in vivo mice sponge implantation assay. Here, gelatin sponge with or without Ethanolic extract of 
Terminalia bellirica leaf (EETB - 0.3 mg and 0.5 mg, respectively) were subcutaneously injected into Swiss 
albino mice, and 14 days later, the implanted sponges was excised and histologically examined. The stained 
section showed that sponge containing EETB had produced more vessels in gels than sponges alone. The 
new vessels were abundantly filled with intact Red blood corpuscles (RBCs), which indicate the formation of 
a functional vasculature inside the sponges and blood circulation in newly formed vessels by angiogenesis 
which is induced by EETB. It also measured that the hemoglobin content inside the sponges: Whereas, 
hemoglobin in control was nearly 0.3 µg, EETB cases the hemoglobin quantity was markedly enhanced to 
about 17 µg. Taken together, it demonstrated that Ethanolic extract of Terminalia bellirica leaf exhibited a 
profound angiogenic activity in vivo. The phytochemical screening and qualitative instrumental analysis of 
EETB reveals the presence of proteins and Phytosterols. The promising angiogenic potential may be due to the 
presence of the above chemical constituents. Further study is required to define more precisely the molecular 
mechanisms by which Ethanolic extract of Terminalia bellirica leaf modulates endothelial cell function and 
gene expression, as well as the pathological relevance of these findings.
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result is either too much or too little angiogenesis. Abnormal 
blood vessel growth, either excessive or insufficient, is now 
recognized as a “common denominator” underlying many 
deadly and debilitating conditions, including cancer, skin 
diseases, age-related blindness, diabetic ulcers, cardiovascular 
disease, stroke, and many others.[1]
Angiogenesis for cardiovascular diseases
Angiogenesis represents an excellent therapeutic target 
for the treatment of cardiovascular diseases. It is a potent 
physiological process that underlies the natural manner 
in which our bodies respond to a diminution of blood 
supply to vital organs, namely the production of new 
collateral vessels to overcome the ischemic state. A large 
number of pre-clinical studies have been performed with 
protein, gene and cell-based therapies in animal models 
of cardiac ischemia as well as models of periphery 
artery diseases. Administration of a particular growth 
factor [Table 1] to stimulate angiogenesis in the affected 
tissues (or) organ, and the protein therapy with single 
protein agent was not a viable option to treat ischemic 
cardiovascular diseases.[2,3]
Therapeutic angiogenesis
Therapeutic angiogenesis is the method of stimulation of 
angiogenesis where it is required but lacking. This technique 
is used to replenish the blood supply to chronic wounds 
to speed healing and it prevents unnecessary amputations. 
New research suggests this approach can be also used to 
save limbs afflicted with poor circulation and even oxygen 
starved hearts.[4] Therapeutic angiogenesis may even help 
to regenerate damaged (or) lost tissues in ways that were 
previously considered impossible, such as, with nerves and 
brain tissues. The modern clinical application of the principle 
of angiogenesis can be divided into two main areas: Anti-
angiogenesis therapies with which angiogenesis research 
began, and with Pro-angiogenic therapies.[5] Antiangiogenic 
therapies are being employed to fight cancer and malignancies 
which require an abundance of oxygen and nutrients to 
proliferate. Pro-angiogenesis therapy is being explored as 
an option to treat cardiovascular diseases. One of the first 
applications of pro-angiogenic methods in humans was a 
German trial using fibroblast growth factor-1 (FGF-1) for 
the treatment of coronary artery diseases. Clinical research in 
therapeutic angiogenesis is ongoing for a variety of diseases 
like coronary artery diseases, peripheral arterial diseases and 
wound healing disorders.  [6] The pro-angiogenesis therapies 
can be differentiated into three categories, namely, i) protein 
therapy,[7] ii) gene therapy[8] and, iii) cell based therapy which 
involved the implantation of specific cell types. Other than 
the above three therapies there are few therapies that have 
been used to induce angiogenesis. Hence, this study is aimed 
to find potent angiogenic herbal compounds. Terminalia 
bellirica has deep roots in Indian mythology as in Ayurveda. It 
is part of a compound rasayana preparation of three myrobalan 
fruits, known as Triphala (or trifla), which are important in 
both Indian and Tibetan traditional medicine. The name 
Vibheekaki indicates that regular use keeps a person healthy 
and free from diseases. It has been previously reported that 
the aqueous extract of fruits of Terminalia bellirica inhibit the 
Tumor Growth and Angiogenesis, and suggests different 
components have different activity, hence, fresh leafs of the 
Terminalia bellirica Roxb, belonging to the family Combretaceae, 
commonly known as Bellirica Myrobalan have been selected 
to evaluate its angiogenesis activity.[9]
MATERIALS AND METHODS
Phytochemical evaluation of plant extract
Plant material
The Fresh leaves of Terminalia bellirica were collected 
from wild area near to Mannargudi, Tiruvarur District, 
Table 1: Endogenous angiogenesis inducers
Type of angiogenesis inducer Examples
Heparin binding peptide growth 
factors
VEGF
PlGF
FGF-1, FGF-2
Pleiotrophin
PDGF
Non-heparin binding peptide 
growth factors
TGF-a TGF-b
EGF
IGF-I
Inflammatory mediators TNF-a
IL-8 IL-3
Prostaglandin E1, E2
Enzymes PD-ECGF/TP
COX-2
Angiogenin
Hormones Oestrogens
Proliferin
Oligosaccharides Hyaluronan
Gangliosides
Hematopoietic factors Erythropoietin
G-CSF
GM-CSF
Cell adhesion molecules VCAM-1
E-Selectin
Others Nitric oxide
Ang-1
Where, VEGF: Vascular endothelial growth factor; PlGF: Placental growth factor; 
FGF-1, FGF-2: Fibroblast growth factors; PDGF: Platelet-derived growth factor; 
TGF-a: Transforming growth factor alpha; TGF-b: Transforming growth factor 
beta; EGF: Epidermal growth factor; IGF-I: Insulin-like growth factor I; TNF-a: 
Tumor necrosis factor alpha; IL-8: Interleukin – 8; IL-3: Interleukin – 3; PD-ECGF/
TP: Platelet-derived endothelial cell growth factor/thymidine phosphorylase; 
COX-2: Cyclooxygenase-2; G-CSF: Granulocyte colony-stimulating factor; GM-
CSF: Granulocyte macrophage colony-stimulating factor; VCAM-1: Vascular cell 
adhesion molecule-1; Ang-1: Angiopoietin 124   Journal of Young Pharmacists Vol 4 / No 1
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Tamil Nadu, India and the same were authenticated 
by Prof. Dr. G.S.V. Murthy-Botanical Survey of India 
(BSI), Coimbatore, India and a voucher specimen No: 
BSI/  SRC/5/23/09-10/Tech-683 was allotted for Terminalia 
bellirica Roxb. [Figure 1]. The herbarium was deposited in 
our University laboratory for further reference.
Preparation of  ethanolic extract
Freshly collected leaves of Terminalia bellirica were shade 
dried and made into small pieces. These pieces were again 
shade dried and pulverized to coarse powder and passed 
through the sieve No: 20, and retained on sieve No: 40. 
About 1 kg of the dry powder of leaves of Terminalia 
bellirica were placed in a thimble of the Soxhlet extraction 
apparatus attached to the mouth of a round bottomed 
flask containing 70% ethanol as an extractive solvent. 
Some boiling chips were added into the flask to avoid 
bumping during heating. Then the dry powder of leaves of 
Terminalia bellirica was extracted for 72 hours. The extract 
was concentrated by rotary vacuum evaporation, and the 
yield was 30% w/w. The dried extract was the subjected 
to phytochemical screening.[10]
Phytochemical screening
Phytochemical screening of EETB was carried out using 
conventional protocol,[11] for detecting the presence of 
different phytochemical active constitutes in the plant 
respectively, and the result is shown in Table 2.
Qualitative instrumental analysis
Ultra violet and visible spectroscopy
The absorption spectra of plant constituents can be 
measured in very dilute solution against a solvent blank using 
an automatic recording spectrophotometer. The ultraviolet 
(UV)-Visible spectroscopy of plant extract shows the peak 
at 255 nm which reveals the presence of proteins.
Infrared spectroscopy
Infrared (IR) spectroscopy is the study of the reflected, 
absorbed or transmitted radiant energy in the region of 
electromagnetic spectrum ranging from wavelength of 
0.8 to 500 nm. Frequency expressed in wave numbers is a 
more commonly used measurement. It is usually divided 
into 3 regions near I.R. (1250 to 400 cm−1), mid I.R. (4000 
to 400 cm−  1) and far I.R. (400 to 20 cm−1). The powdered 
EETB was mixed with potassium bromide and a thin disc 
was prepared in anhydrous conditions. That disc was used 
for the measurement of I.R. spectra against the potassium 
bromide disc as reference. The Fourier transform infrared 
FT-  IR-spectra of ethanolic extract of Terminalia bellirica leaf 
contains main absorption bands belonging to the valence 
vibrations corresponding to OH, C=O, C-O-C groups to 
aromatic rings vibrations as well shows in Figure 2. Spectra 
examination reveals that the valence vibrations appears 
in the 2916 cm−1 S (CH3CH2) band, 2849 cm−1 (C-H), 
1713 (C=O) cm−1, 1612 cm−1 (aromatic C=O), 1450 cm−1 
(aromatic C=C ring), 758 and 870 cm−1 (benzene ring), 
and may be due to the presence of Phytosterols. Also, it 
is found that the plant contains organic compounds like 
carbohydrates, cardiac glycosides, chlorophyll and lignins.
Evaluation and quantification of angiogenesis activity
Animals
Seven-week-old, specific pathogen-free Male Swiss albino 
mice weighing between (32 – 34 gm) were purchased from 
Tamil Nadu Veterinary and Animal Sciences University, 
Chennai. They were housed in poly propylene cages (4 per 
cage), maintained in standard lab conditions at 25 ± 2oC, 10% 
humidity under a 12 hour light/dark cycle. They were fed with 
standard pellet diet and autoclaved tap water ad libitum. All 
procedures were performed with the animals under general 
Figure 1: Leaves of Terminalia bellirica Roxb
Figure 2: Fourier transform infrared (FT IR) spectra of ethanolic extract 
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anesthesia, that is, after intraperitoneal injection of sodium 
phenobarbitone (30 mg/kg). This study was approved 
by the Institutional Animal Ethical Committee (IAEC), 
Approval No: Pharm/12/2009-2010, and the all the animal 
experiments were performed according to the strict guidelines 
prescribed by Committee for the purpose of control and 
supervision on experiments on animals (CPCSEA).
Acute toxicity studies
Acute toxicity study was carried out on plant extract using 
female and male Swiss albino mice. The mice were fasted 
overnight and the weight of each mouse was recorded 
just before use. The extract was subjected for acute 
toxicity studies by following the OECD (Organization for 
Economical Co-operation and Development) guidelines 
No. 425. A group of 5 mice was administered the plant 
extract in graded doses of 0.25 g/kg, 0.5 g/kg, 1.0 g/  kg, 
1.5 g/kg, and 2.5 g/kg mice. Mice were continuously 
observed for mortality and behavioral response for 48 
hours. The dose selection was performed by taking 1/10th 
of the lethal dose (LD5O).
Mice sponge implantation method
The in vivo angiogenesis assay involving subcutaneous 
implantation of gelfoam sponges in mice was performed 
according to the method proposed by Vallera et al., 
and Mc Carty et al., Absorbable gel foam was cut 
(5 mm × 5 mm × 5 mm) and hydrated in sterile normal 
saline (0.9%), and strengthened with sterile 0.4% agarose.  [12] 
Mice were divided into four groups and each group 
contains six animals. Mice were anaesthetized with sodium 
phenobarbitone (30 mg/kg, i.p.). The caudal region of 
the back was shaved and scrubbed with 95% ethanol. 
An incision was made and a sponge wetted with sterile 
normal saline was inserted into each subcutaneous pocket 
created under the upper flap and pushed cephalad. This 
helps to decrease the incident of infection, and reduces 
the complications resulting from scar tissue forming. 
Immediately, the incision was sutured. The test and Pyruvic 
Acid which is used as standard substances were injected 
slowly through the skin into the sponges by using water as 
a vehicle. Animals were allowed to recover for 14 days.[13]
Hemoglobin determination in implanted sponges
On 14th day animals were sacrificed with an overdose of 
sodium phenobarbitone, and the sponges were harvested 
from the mice, and were carefully stripped of any remaining 
peritoneum. The sponges were weighed by placing them 
into preweighed 1 ml tube of double distilled H2O and 
homogenized for 5–10 minutes on ice. The samples were 
spun at 10,000 revolutions per minute (rpm) on a micro 
centrifuge for 6 minutes, and the supernatants were collected 
for hemoglobin measurement. The supernatants were 
filtered through a 0.22-µm filter, and fifty micro liters of 
supernatant were mixed with Drabkin’s reagent, and allowed 
to sit at room temperature for 15–30 minutes). Hemoglobin 
(Hb) in the samples was quantified calorimetrically at 
540 nm in a spectrophotometer. The concentration of 
hemoglobin was calculated from a known amount of 
hemoglobin assayed in parallel. The results were expressed 
as Hb µg/mg wet sponges.[14]
RESULTS
Phytochemical screening and qualitative instrumental 
analysis
The phytochemical screening of plant extract revealed 
the presence of proteins, steroids and terpinoids. The 
UV-  Visible spectroscopy of the plant extract gives 
maximum absorption at 255 nm. The presence of proteins 
may have revealed the presence of CH3CH2, (C-H), C=O, 
aromatic C=O, aromatic C=C ring, and benzene ring in 
the IR-spectra of the plant extract.
Ethanolic extract of Terminalia bellirica leaf 
stimulates angiogenesis in vivo
The in vivo angiogenesis activity was then evaluated by 
the effect of EETB leaf on the ongoing angiogenesis 
process in the in vivo mice sponge implantation assay. 
Gelatin sponge with or without EETB leaf (0.3 mg 
Table 2: Preliminary phytochemical screening of 
Terminalia bellirica Roxb. during the study
Phytochemical 
test
Test methods/reagents Results
Alkaloids Mayer’s
Dragendroff’s
- 
-
Carbohydrates 
and glycosides
Molisch’s
Borntrager’s
- 
-
Cardiac 
glycosides
Legal’s test
Kellerkilliani test
- 
-
Sugars Fehling’s test
Benedict’s test
- 
-
Steroids Liebermann’s Burchard test
Salkowski test
++
++
Tannins Lead solution
Aqueous gelatin solution
- 
-
Proteins Million’s test
Biuret test
Ninhydrin test
Xanthoprotein test
++
++
++
++
Terpenoids Noller’s test +
Flavonoids Shinoda test -
Anthocyanins NaOH and conc. sulphuric acid -
Quinones Sodium hydroxide (NaOH) test -
+ indicates the presence of phytochemical, ++ Indicates the presence of more 
quantity, - indicates the absence of phytochemical26   Journal of Young Pharmacists Vol 4 / No 1
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and 0.5 mg, respectively) was subcutaneously injected 
into Swiss albino mice, and 14 days later, the implanted 
sponges in mice was excised and histological examined. 
Gelatin sponges alone were pale in their color indicating 
no or less blood vessel formation. In contrast, sponges 
mixed with EETB leaf appeared dark-red in color. As 
the sponges were treated with 0.5 mg of EETB leaf, they 
contained too many large vessels to perform histological 
examination [Figure 3]. The stained section showed that 
sponge containing EETB leaf had produced more vessels 
in gels than sponges alone [Figure 4]. The new vessels 
were abundantly filled with intact RBCs, which indicated 
the formation of a functional vasculature inside the 
sponges, and blood circulation in newly formed vessels 
by angiogenesis, induced by EETB leaf. It also measured 
the hemoglobin content inside the sponges [Table 3] to 
quantify the angiogenesis induced by EETB leaf. Whereas 
hemoglobin in control was nearly 0.3 µg, the hemoglobin 
content was markedly enhanced by EETB to about 17 µg. 
Taken together, It is proved that EETB leaf exhibited a 
profound angiogenic activity in vivo.
Statistical analysis
All the values are expressed as Mean ± SEM (n=6) and 
***P< 0.001 considered as significant when compared 
to control. Statistical comparisons between control and 
treated groups were carried out using one-way analysis 
of variances (ANOVA) and differences between groups 
assessed using Dunnet’s t test. All statistical analysis was 
done by using Graph Pad Prism 5 software.
DISCUSSION
Therapeutic angiogenesis is the method of stimulation of 
angiogenesis where it is required but lacking. This technique 
is used to replenish the blood supply to chronic wounds 
to speed healing and it prevents unnecessary amputations. 
New research also suggests that this approach can be also 
used to save limbs afflicted with poor circulation and even 
oxygen starved hearts. Therapeutic angiogenesis may even 
help to regenerate damaged (or) lost tissues in ways that 
were previous considered impossible such as with nerves 
and brain tissues. Developing novel angiogenic agents 
that have a well-developing mechanism of action is most 
important in angiogenesis field. Three types of therapies 
were developed up to now: Namely, protein therapy; gene 
transfer technology; and, stem cell transplantation which 
were most costly and have side effects. In this direction, 
the plants are being actively explored as a source of new 
molecules that can induces angiogenesis. In the present 
study, we have clearly elucidated the angiogenic activity 
of EETB leaf by performing in vivo angiogenesis assays. 
In mice sponge implantation assay, EETB highly elevated 
the formation of neovessels in implanted sponges and 
these newly synthesized vessels participated actively in 
the circulating of blood cells in mice [Figure 3]. Taken 
together, the observations in the present study suggest that 
EETB leaf exhibits strong angiogenic actions, and also may 
have the potential to be a useful modulator of the large 
number of serious diseases characterized by deregulated 
angiogenesis.
CONCLUSION
The preliminary phytochemical screening of the 
EETB has showed the presence of proteins, sugars, 
Figure 4: (a) The sponge without pro-angiogenic agent does not show 
blood vessel supply. However, the sponge with Pyruvic acid 500 µg 
(b) shows angiogenesis and the sponge with Terminalia bellirica leaf 
extract (500 µg) shows (c) many blood vessels appeared
Figure 3: Angiogenesis induced by Terminalia bellirica in in-vivo 
mice sponge implantation assay. a) The sponge alone. b) Sponge 
with Pyruvic acid (500 µg). c) Sponge with Terminalia bellirica extract 
(500 µg)
Table 3: Angiogenesis activity induced by ethanolic 
extract of Terminalia bellirica leaf in mice sponge 
implantation method
Group Treatment Hemoglobin present 
hemoglobin  
µg/mg wet sponge 
(mean±standard 
error of Mean)
Control Gel foam 0.317 ± 0.031
Standard Gel foam+P.A. (500 µg) 22.667 ± 0.667***
Test A Gel foam+T.B. (300 µg) 10.667 ± 0.882***
Test B Gel foam+T.B. (500 µg) 17.667 ± 0.882***
All the results were expressed as mean±SEM and ***P< 0.001, **P<0.005 and 
*P<0.05 considered as a significant where (n.s) as not significantJournal of Young Pharmacists Vol 4 / No 1  27
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phytosterols, Terpinoids and tannins. The acute toxicity 
study was carried out and a dose level of 2000 mg/kg 
body weight orally in mice was considered to be safe 
for pharmacological treatment. The results of this study 
support the development and use of Terminalia bellirica as 
a well-tolerated, safe and less cost angiogenic agent with 
potential angiogenic therapy. The hemoglobin present in 
the extract treated group was increased when compare to 
the control group implanted sponges. The histopathology 
of the implanted sponges shows the presence of the 
blood vessels in the extract treated groups. Thus, from 
the foregoing findings it was observed that leaf of 
Terminalia bellirica is a promising angiogenic agent, and 
this angiogenic activity may be due to the presence of 
proteins. This is the first report which is not previously 
said, as well as not yet it is reported that plant proteins 
inhibit angiogenesis. Further study is required to define 
more precisely the molecular mechanisms by which 
proteins of EETB leaf modulate endothelial cell function 
and gene expression, as well as the pathological relevance 
of these findings.
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